Skip to main content

Advertisement

Log in

Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Background

Anogenital warts are a common human papillomavirus infection. They cause emotional distress, especially when they are in the anogenital region. Cryotherapy is a first-line treatment. Previous clinical trials and case series have reported variable results with retinoids (isotretinoin) as adjuvant therapy.

Objective

To determine the safety and efficacy of low-dose oral isotretinoin as adjuvant treatment of anogenital warts.

Methods

Forty-six patients with anogenital warts were randomly assigned to isotretinoin + cryotherapy (n = 23) or only cryotherapy (n = 23). Patients were allocated via an interactive web-based randomization system. Evaluators were blinded to treatments. Isotretinoin 20 mg/daily + cryotherapy or cryotherapy were prescribed for 6 weeks. Patients were followed for 4 months. Genotyping of lesions was performed before treatment started. Dermatology Life Quality Index (DLQI) and Columbia-Suicide Severity Rating Scale (C-SSRS) were measured at the beginning and end of therapy. All patients completed the study.

Results

Both Groups had 50% clearance at the end of treatment. Recurrence in the combined group was not significantly lower than in the cryotherapy group (P = 0.59). Improvement was observed in the DLQI of all patients in both groups (P = 0.001). No suicidal intention was detected with the C-SSRS. Two patients (one in each group) had liver function test abnormalities after treatment.

Conclusion

Combined therapy showed a slight not significant efficacy for anogenital warts in Hispanic patients. Low-dose isotretinoin seems to be safe even when it is used with cryotherapy on anogenital warts.

Trial registration

On April 25, 2019 with registration number DE19-00004, CONBIOÉTICA-19-CEI-001–20160404. Prospectively registered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Aubin F, Prétet JL, Jacquard AC et al (2008) Human papillomavirus genotype distribution in external acuminata condylomata: a large French national study (EDiTH IV). Clin Infect Dis 47:610–615. https://doi.org/10.1086/590560

    Article  PubMed  Google Scholar 

  2. Ingles DJ, Pierce Campbell CM, Messina JA, Stoler MH, Lin HY, Fulp WJ et al (2014) Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV infection in men (HIM) Study. J Infec Dis. 211(7):1060–1067. https://doi.org/10.1093/infdis/jiu587

    Article  Google Scholar 

  3. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110(5):525–541. https://doi.org/10.1042/CS20050369

    Article  CAS  Google Scholar 

  4. Christensen ND, Cladel NM, Reed CA, Han R (2000) Rabbit oral papillomavirus complete genome sequence and immunity following genital infection. Virology 269:451–461. https://doi.org/10.1006/viro.2000.0237

    Article  CAS  PubMed  Google Scholar 

  5. Messing AM, Epstein WL (1963) Natural history of warts: a two year study. Arch Dermatol 87:301–310. https://doi.org/10.1001/archderm.1963.01590150022004

    Article  Google Scholar 

  6. Sterling JC, Gibbs S, Haque Hussain SS, Mohd Mustapa MF, Handfield-Jones SE (2014) British Association of Dermatologists’ guidelines for the management of cutaneous warts 2014. Br J Dermatol 171:696–712. https://doi.org/10.1111/bjd.13310

    Article  CAS  PubMed  Google Scholar 

  7. Stanley MA (2009) Immune responses to human papilloma viruses. Indian J Med Res 130:266–276

    CAS  PubMed  Google Scholar 

  8. Lacey CJN, Woodhall SC, Wikstrom A et al (2013) 2012 European guideline for the management of anogenital warts. J Eur Acad Dermatol Venereol 27:e263–e270. https://doi.org/10.1111/j.1468-3083.2012.04493.x

    Article  CAS  PubMed  Google Scholar 

  9. Centers for Disease Control. STD treatment guidelines. Available at: http://www.cdc.gov/std/tg2015/. Published 2015. Accessed on June, 22 2020.

  10. Bertolotti A, Dupin N, Bouscarat F, Milpied B, Derancourt C (2017) Cryotherapy to treat anogenital warts in nonimmunocompromised adults: Systematic review and meta-analysis. J Am Acad Dermatol 77(3):518–526. https://doi.org/10.1016/j.jaad.2017.04.012

    Article  PubMed  Google Scholar 

  11. Stellmach V, Leask A, Fuchs E (1991) Retinoid-mediated transcriptional regulation of keratin genes in human epidermal and squamous cell carcinoma cells. Proc Natl Acad Sci USA 88:45–82

    Article  Google Scholar 

  12. Mucida D, Park Y, Kim G et al (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256–260. https://doi.org/10.1126/science.1145697

    Article  CAS  PubMed  Google Scholar 

  13. Jason J, Archibald LK, Nwanyanwu OC (2002) Vitamin A levels and immunity in humans. Clin Diagn Lab Immunol 9:616–621. https://doi.org/10.1128/cdli.9.3.616-621.2002

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Bartsch D, Boye B, Baust C et al (1992) Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11:2283–2291

    Article  CAS  Google Scholar 

  15. Faluhelyi Z, Rodler I, Csejtey A et al (2004) All-trans retinoic acid (ATRA) suppresses transcription of human papillomavirus type 16 (HPV16) in a dose-dependent manner. Anticancer Res 24:807–809

    CAS  PubMed  Google Scholar 

  16. Reppucci A, DiLorenzo T, Abramson A et al (1991) In vitro modulation of human laringuela papillota cell differentiation by retinoic acid. Otolaryngol Head Neck Surg 105:528–532. https://doi.org/10.1177/019459989110500404

    Article  CAS  PubMed  Google Scholar 

  17. El-Esawy F, Mustafa AI, El-Shimi O (2019) Serum retinol-binding protein: a novel biomarker for recalcitrant cutaneous warts. Int J Dermatol 58(12):1435–1438. https://doi.org/10.1111/ijd.14475

    Article  CAS  PubMed  Google Scholar 

  18. Olsen EA, Kelly FF, Vollmer RT, Buddin DA, Weck PK (1989) Comparative study of systemic interferon alfa-nl and isotretinoin in the treatment of resistant condylomata acuminata. J Am Acad Dermatol 20(6):1023–1030. https://doi.org/10.1016/s0190-9622(89)70127-4

    Article  CAS  PubMed  Google Scholar 

  19. Cardamakis E, Kotoulas IG, Relakis K, Metalinos K, Michopoulos J, Stathopoulos E et al (1995) Comparative study of systemic interferon alfa-2a plus isotretinoin versus isotretinoin in the treatment of recurrent condyloma acuminatum in men. Urology 45:857–860. https://doi.org/10.1016/S0090-4295(99)80094-6

    Article  CAS  PubMed  Google Scholar 

  20. Cardamakis EK, Kotoulas IG, Dimopoulos DP, Stathopoulos EN, Michopoulos JT, Tzingounis VA (1996) Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata. Arch Gynecol Obstet 258:35–41. https://doi.org/10.1007/BF01370930

    Article  CAS  PubMed  Google Scholar 

  21. Georgala S, Katoulis AC, Georgala C, Bozi E, Mortakis A (2004) Oral isotretinoin in the treatment of recalcitrant condylomata acuminata of the cervix: a randomised placebo controlled trial. Sex Transm Infect 80:216–218. https://doi.org/10.1136/sti.2003.006841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Olguín-García MG, Jurado-Santa Cruz F, Peralta-Pedrero ML, Morales-Sánchez MA (2015) A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts. J Dermatolog Treat 26:78–82

    Article  Google Scholar 

  23. Kaur GJ, Brar BK, Kumar S, Brar SK, Singh B (2017) Evaluation of the efficacy and safety of oral isotretinoin versus topical isotretinoin in the treatment of plane warts: a randomized open trial. Int J Dermatol 56(12):1352–1358. https://doi.org/10.1111/ijd.13727

    Article  CAS  PubMed  Google Scholar 

  24. Tsambaos D, Georgiou S, Monastirli A, Sakkis T, Sagriotis A, Goerz G (1997) Treatment of condylomata acuminata with oral isotretinoin. J Urol 158:1810–1812. https://doi.org/10.1016/s0022-5347(01)64136-3

    Article  CAS  PubMed  Google Scholar 

  25. Olguín-García MG, Cancela RG, Peralta-Pedrero ML (2010) Estudio preexperimental para el tratamiento de verrugas planas faciales con isotretinoı’na oral. Dermatol Rev Mex 54:267–272

    Google Scholar 

  26. Al-Hamamy HR, Salman HA, Abdulsattar NA (2012) Treatment of plane warts with a low-dose oral isotretinoin. ISRN Dermatol 2012:163929. https://doi.org/10.5402/2012/163929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Katz RA (1986) Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. Arch Dermatol 122(1):19–20. https://doi.org/10.1001/archderm.1986.01660130021014

    Article  CAS  PubMed  Google Scholar 

  28. Yildirim M, Inaloz HS, Baysal V, Kesici D, Candir O (2004) A case of condyloma acuminatum treated successfully with low-dose isotretinoin and interferon. Int J Clin Pract 58(9):889–891. https://doi.org/10.1111/j.1742-1241.2004.00071.x

    Article  CAS  PubMed  Google Scholar 

  29. Monastirli A, Matsouka P, Pasmatzi E, Melachrinou M, Georgiou S, Solomou E et al (2005) Complete remission of recalcitrant viral warts under oral isotretinoin in a patient with low-grade b-cell lymphoma. Acta Derm Venereol 1(1):1–1. https://doi.org/10.1080/00015550510027090

    Article  Google Scholar 

  30. Miljkovic J (2012) A novel therapeutic approach to plane warts: a report on two cases. Acta Dermatovenerol Alp Pannonica Adriat 21:63–64

    PubMed  Google Scholar 

  31. Pasmatzi E, Kapranos N, Monastirli A, Melachrinou M, Georgiou S, Tsambaos D (2012) Large benign condyloma acuminatum: successful treatment with isotretinoin and interferon alpha. Acta Derm Venereol 92(3):249–250. https://doi.org/10.2340/00015555-1257

    Article  CAS  PubMed  Google Scholar 

  32. Yew YW, Pan JY (2013) Complete remission of recalcitrant genital warts with a combination approach of surgical debulking and oral isotretinoin in a patient with systemic lupus erythematosus. Dermatol Ther 27(2):79–82. https://doi.org/10.1111/dth.12059

    Article  PubMed  Google Scholar 

  33. Jha AK, Sonthalia S, Ganguly S (2018) Oral isotretinoin as an adjunctive treatment for recurrent genital warts. J Am Acad Dermatol 78(2):e35–e36. https://doi.org/10.1016/j.jaad.2017.08.057

    Article  PubMed  Google Scholar 

  34. Białecka A, Męcińska-Jundziłł K, Adamska U, Cichewicz A, Białecki M, Drewa G, Czajkowski R (2018) Plane warts on the back of the hand successfully treated with oral isotretinoin. Postepy Dermatol Alergol 35(2):227–229. https://doi.org/10.5114/pdia.2017.70259

    Article  PubMed  PubMed Central  Google Scholar 

  35. Herold M, Nielson C, Longo MI (2018) Isotretinoin and Candida immunotherapy for recalcitrant warts in solid organ transplant recipients. Derm Ther. https://doi.org/10.1111/dth.12803

    Article  Google Scholar 

  36. Yang TH, Lee TH, Huang YC (2019) Oral isotretinoin for treating mucocutaneous human papillomavirus infections: a systematic review and meta-analysis. Indian J Dermatol Venereol Leprol 85:569–577. https://doi.org/10.4103/ijdvl.IJDVL_269_18

    Article  PubMed  Google Scholar 

  37. Moreira ED Jr, Giuliano AR, Palefsky J, Flores CA, Goldstone S, Ferris D et al (2014) Incidence, clearance, and disease progression of genital human papillomavirus infection in heterosexual men. J Infect Dis 210:192–199. https://doi.org/10.1093/infdis/jiu077

    Article  CAS  PubMed  Google Scholar 

  38. Camargo CC, D’Elia MPB, Miot HA (2017) Quality of life in men affected by anogenital warts. An Bras Dermatol 92(3):427–429. https://doi.org/10.1590/abd1806-4841.20175282

    Article  PubMed  PubMed Central  Google Scholar 

  39. Al-Awadhi R, Al-Mutairi N, Albatineh AN, Chehadeh W (2019) Association of HPV genotypes with external anogenital warts: a cross sectional study. BMC Infect Dis 19(1):375. https://doi.org/10.1186/s12879-019-4005-4

    Article  PubMed  PubMed Central  Google Scholar 

  40. Dave DD, Abdelmaksoud A (2019) Low dose Isotretinoin as an adjuvant therapy for treatment of different clinical variants of warts: a case series. Dermatol Ther. https://doi.org/10.1111/dth.12836

    Article  PubMed  Google Scholar 

  41. Giuliano AR, Sirak B, Abrahamsen M, Silva RJC, Baggio ML, Galan L et al (2019) Genital wart recurrence among men residing in Brazil, Mexico, and the United States. J Infect Dis 219(5):703–710. https://doi.org/10.1093/infdis/jiy533

    Article  PubMed  Google Scholar 

  42. Sundström A, Alfredsson L, Sjölin-Forsberg G, Gerdén B, Bergman U, Jokinen J (2010) Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study. BMJ 341:c5812. https://doi.org/10.1136/bmj.c5812

    Article  PubMed  PubMed Central  Google Scholar 

  43. Huang YC, Cheng YC (2017) Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis. J Am Acad Dermatol 76(6):1068–76.e9. https://doi.org/10.1016/j.jaad.2016.12.028

    Article  CAS  PubMed  Google Scholar 

  44. Singer S, Tkachenko E, Sharma P, Barbieri JS, Mostaghimi A (2019) Psychiatric adverse events in patients taking isotretinoin as reported in a food and drug administration database from 1997 to 2017. JAMA Dermatol 155(10):1162–1166. https://doi.org/10.1001/jamadermatol.2019.1416

    Article  PubMed  PubMed Central  Google Scholar 

  45. Droitcourt C, Poizeau F, Kerbrat S et al (2019) Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010–2014 French Health Insurance Data. J Eur Acad Dermatol Venereol. https://doi.org/10.1111/jdv.16005 (published online ahead of print, 2019 Oct 6)

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank all the patients who participated in this study. Thanks to Dr Sergio Lozano, for his support in the English language writing.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

Authors

Contributions

ILRR obtained compiled, analyzed all data, and prepared initial draft. ILRR, SCA, VGR and AVM analyzed and interpreted data, drafted, and critically evaluated the manuscript for important intellectual content. ILRR, SCA, VGR, AVM, GGM, RFM and JOC helped in obtaining, compiling and interpretation of data, and literature search. ILRR evaluated clinical response and SCA, VGR and AVM assessed pre- and post-treatment photographs. All authors were involved in the drafting and revision of the manuscript and have agreed to the final content.

Corresponding author

Correspondence to Alejandra Villarreal-Martinez.

Ethics declarations

Conflict of interest

All authors declare that they have no competing interest and therefore nothing else to declare, and have contributed significantly and take full responsibility for the manuscript. The authors of the paper are obliged to confirm that it has not been previously published.

Ethical approval

This study was registered and approved (registration number: DE19-00004) by the Institutional Review Board Ethical Committee of the Dr. Jose Eleuterio González University Hospital of the Universidad Autónoma de Nuevo León, Mexico (CONBIOÉTICA-19-CEI-001-20160404).

Informed consent

Informed consent was obtained from study subjects for enrollment and publication of material with the understanding that their names and initials will not be published and due efforts will be made to conceal their identity but anonymity cannot be guaranteed. All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki declaration of 1975 as revised in 1983.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reyna-Rodríguez, I.L., Chavez-Alvarez, S., Garza-Rodríguez, V. et al. Cryotherapy plus low-dose oral isotretinoin vs cryotherapy only for the treatment of anogenital warts: a randomized clinical trial. Arch Dermatol Res 313, 815–827 (2021). https://doi.org/10.1007/s00403-020-02182-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-020-02182-y

Keywords

Navigation